Area of research
Genetics · Hematology
Research interest
Research focused on Real-time polymerase chain reaction and Thrombocytosis, with related work in Vemurafenib, Minimal residual disease, Myelofibrosis. Notable publications include 'Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative...', 'Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK 2 V 617 F and other relevant mutations', and 'A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR'.
Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies
A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions
Molecular diagnosis of the myeloproliferative neoplasms: <scp>UK</scp> guidelines for the detection of <i><scp>JAK</scp>2 </i><scp>V</scp>617<scp>F</scp> and other relevant mutations
Rapid response of biallelic <i> <scp>BRAF</scp> </i> <scp>V</scp> 600 <scp>E</scp> mutated hairy cell leukaemia to low dose vemurafenib